1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015

Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015" provides data on the Anaplastic Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anaplastic Thyroid Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Anaplastic Thyroid Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Anaplastic Thyroid Cancer 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Anaplastic Thyroid Cancer Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
OXiGENE, Inc. 33
Clinical Trial Overview of OXiGENE, Inc. 33
Bayer AG 34
Clinical Trial Overview of Bayer AG 34
Eisai Co., Ltd. 35
Clinical Trial Overview of Eisai Co., Ltd. 35
Daiichi Sankyo Company, Limited 36
Clinical Trial Overview of Daiichi Sankyo Company, Limited 36
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Genelux Corporation 38
Clinical Trial Overview of Genelux Corporation 38
Clinical Trial Overview of Top Institutes / Government 39
National Cancer Institute 39
Clinical Trial Overview of National Cancer Institute 39
Case Comprehensive Cancer Center 40
Clinical Trial Overview of Case Comprehensive Cancer Center 40
Memorial Sloan Kettering Cancer Center 41
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 41
Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino 42
Clinical Trial Overview of Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino 42
University of Schleswig-Holstein 43
Clinical Trial Overview of University of Schleswig-Holstein 43
University of Colorado 44
Clinical Trial Overview of University of Colorado 44
University of Michigan Comprehensive Cancer Center 45
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 45
University of Kentucky 46
Clinical Trial Overview of University of Kentucky 46
Leiden University Medical Center 47
Clinical Trial Overview of Leiden University Medical Center 47
Five Key Clinical Profiles 48
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 80

List of Tables
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Anaplastic Thyroid Cancer Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Anaplastic Thyroid Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Anaplastic Thyroid Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Anaplastic Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by OXiGENE, Inc., 2015* 33
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 34
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 35
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 36
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 37
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genelux Corporation, 2015* 38
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 39
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015* 40
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 41
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino, 2015* 42
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Schleswig-Holstein, 2015* 43
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2015* 44
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2015* 45
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2015* 46
Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 47

List of Figures
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15
Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18
Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Anaplastic Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 78

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.